Skip to the content

Publications

USRDS publications are listed by the most recent and include a 10-year period of research. For older publications, please contact us. Publications based upon USRDS data must include the following notice:

The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

 

Publications

Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study. Woodside KJ, Bell S, Mukhopadhyay P, Repeck KJ, Robinson IT, Eckard AR, Dasmunshi S, Plattner BW, Pearson J, Schaubel DE, Pisoni RL, Saran R. American Journal of Kidney Diseases. 2018 Feb 9.

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States. Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK. Circulation. 2018 Jul 3.

Publications

Explaining trends and variation in timing of dialysis initiation in the United States. Li Y, Jin Y, Kapke A, Pearson J, Saran R, Port FK, Robinson BM. Medicine. 2017 May 19;96(20):e6911.

Conditional modeling of longitudinal data with terminal event. Kong S, Nan B, Kalbfleisch JD, Saran R, Hirth R. Journal of the American Statistical Association. 2017 Nov 13;10:1-2.

Strengthening instrumental variables through weighting. Lehmann D, Li Y, Saran R, Li Y. Statistics in Biosciences. 2017 Dec;9(2):320-338.

Publications

A weighted instrumental variable estimator to control for instrument-outcome confounders. Lehmann D, Li Y, Saran R, Li Y. The University of Michigan Department of Biostatistics Working Paper Series. 2016 Apr; Working Paper 121:1-30.

Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. The Lancet. 2016 Jul 16;388(10041):294-306.

Risk of ESRD in the United States. Albertus P, Morgenstern H, Robinson B, Saran R. American Journal of Kidney Diseases. 2016 Dec 1;68(6):862-72.

Publications

Agreement of reported vascular access at hemodialysis initiation. Solid CA, Collins AJ, Ebben JP, Chen SC, Faravardeh A, Foley RN, Ishani A. BMC Nephrol. 2014;15:30.

Publications

The USRDS: What you need to know about what it can and can’t tell us about ESRD. Foley RF, Collins AJ. Clin J Am Soc Nephrol. 2013;8:845-851.

Incidence of stroke before and after dialysis initiation in older patients. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA. J Am Soc Nephrol. 2013;24:1166-11.

Publications

Issues regarding ‘immortal time’ in the analysis of the treatment effects in observational studies. Liu J, Weinhandl ED, St. Peter WL. Kidney Int. 2012;81:341-350.

Timing of arteriovenous fistula placement and Medicare costs during hemodialysis initiation. Solid C, Carlin C. Am J Nephrol. 2012;35:498-508.

Sources of drug coverage among Medicare beneficiaries with end-stage renal disease. Howell BL, Powers CA, Weinhandl ED, St. Peter WL, Frankenfield DL. J Am Soc Nephrol. 2012;23:959-965.

Publications

Kidney function and risk triage in adults: threshold values and hierarchical importance. Foley RN, Wang C, Snyder JJ, Rule AD, Collins AJ. Kidney Int. 2011;79:99-111.

Long interdialytic interval and mortality among patients receiving hemodialysis. Foley RN, Gilbertson DT, Murray T, Collins AJ. New Engl J Med. 2011;365:1099-1107.

Kidney function reference values in US adolescents: National Health and Nutrition Examination Survey 1999-2008. Chavers BM, Rheault MN, Foley RN. Clin J Am Soc Nephrol. 2011;6:1956-1962.

Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance. Foley RN, Wang C, Collins AJ. Nephrol Dial Transplant. 2011;26:1831-1837.

Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. Slinin Y, Guo H, Gilbertson DT, Mau LW, Ensrud K, Collins AJ, Ishani A. Am J Kidney Dis. 2011;58:583-590.

Publications

An improved comorbidity index for outcome analyses among dialysis patients. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. Kidney Int. 2010;77:141-151.

Economic effect of following HbA1c testing practice guidelines in the elderly Medicare population: An instrumental variable analysis. Li S, Liu J, Gilbertson DT, Collins AJ. Am J Med Qual. 2010;25:202-210.

Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year. Slinin Y, Guo H, Gilbertson DT, Mau LW, Ensrud K, Rector T, Collins AJ, Ishani A. Clin J Am Soc Nephrol. 2010;5:1574-1581.

USRDS Data Publication

Planned publications based on USRDS data must be submitted for privacy assurance review to the USRDS Coordinating Center at usrds@usrds.org, along with the USRDS Manuscript Approval Request Checklist (PDF) . Please use the subject line: “USRDS manuscript.” Privacy assurance requests should also include the approved Data Use Agreement (DUA) number.

USRDS Coordinating Center (CC)

Tel: 1.888.99USRDS
      (1.888.998.7737)

Email: usrds@usrds.org